Histone deacetylase inhibitors cooperate with IFN-γ to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8

被引:91
|
作者
Haecker, S. [1 ]
Dittrich, A. [1 ]
Mohr, A. [2 ]
Schweitzer, T. [3 ]
Rutkowski, S. [4 ]
Krauss, J. [3 ]
Debatin, K-M [1 ]
Fulda, S. [1 ]
机构
[1] Univ Childrens Hosp, D-89075 Ulm, Germany
[2] Natl Univ Ireland, NCBES, Mol Therapeut Grp, Galway, Ireland
[3] Univ Wurzburg, Dept Neurosurg, Wurzburg, Germany
[4] Univ Wurzburg, Dept Pediat, Wurzburg, Germany
关键词
caspase-8; apoptosis; TRAIL; HDACI; medulloblastoma; UP-REGULATING CASPASE-8; DRUG-INDUCED APOPTOSIS; INTERFERON-GAMMA; DEATH RECEPTOR; CELL-DEATH; CHILDHOOD MEDULLOBLASTOMA; PANCREATIC-CARCINOMA; NEUROBLASTOMA-CELLS; EWINGS-SARCOMA; TUMOR CELLS;
D O I
10.1038/onc.2009.161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Evasion of apoptosis can be caused by epigenetic silencing of caspase-8, a key component of the extrinsic apoptosis pathway. Loss of caspase-8 correlates with poor prognosis in medulloblastoma, which highlights the relevance of strategies to upregulate caspase-8 to break apoptosis resistance. Here, we develop a new combinatorial approach, that is treatment using histone deacetylase inhibitors (HDACI) together with interferon (IFN)-gamma, to restore caspase-8 expression and to overcome resistance to the death-receptor ligand TNF-related apoptosis-inducing ligand (TRAIL) in medulloblastoma in vitro and in vivo. HDACI, for example, valproic acid (VA), suberoylanilide hydroxamic acid (SAHA) and MS-275, cooperate with IFN-gamma to upregulate caspase-8 in cancer cells lacking caspase-8, thereby restoring sensitivity to TRAIL-induced apoptosis. Molecular studies show that VA promotes histone acetylation and acts in concert with IFN-gamma to stimulate caspase-8 promoter activity. The resulting increase in caspase-8 mRNA and protein expression leads to enhanced TRAIL-induced activation of caspase-8 at the death-inducing signaling complex, mitochondrial outer-membrane permeabilization and caspase-dependent cell death. Intriguingly, pharmacological or genetic inhibition of caspase-8 also abolishes the VA/IFN-gamma-mediated sensitization for TRAIL-induced apoptosis. It is important to note that VA and IFN-gamma restore caspase-8 expression and sensitivity to TRAIL in primary medulloblastoma samples and significantly potentiate TRAIL-mediated suppression of medulloblastoma growth in vivo. These findings provide the rationale for further (pre)clinical evaluation of VA and IFN-gamma to restore caspase-8 expression and apoptosis sensitivity in cancers with caspase-8 silencing and open new perspectives to overcome TRAIL resistance. Oncogene (2009) 28, 3097-3110; doi: 10.1038/onc.2009.161; published online 13 July 2009
引用
收藏
页码:3097 / 3110
页数:14
相关论文
共 50 条